Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-05

Clinical Trial Update: Effect of Taurolidin on Prevention of Bloodstream Infection [NA]

View source ↗

Summary

This ClinicalTrials.gov update reports termination of a trial evaluating taurolidin for preventing bloodstream infections in sepsis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taurolidin (taurolidine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Sepsis | NA | Status: TERMINATED